What We Do

Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. Diseases like Alzheimer’s and Parkinson’s are placing a large and increasing burden on society and, without intervention, the costs to manage these diseases will rise ten-fold within a generation.

As a part of our Healthy Aging Strategy, we aim to reduce the burden of neurodegenerative diseases of aging on Canadians by supporting the investigation of novel lifestyle approaches, and accelerating the development of therapeutics. To achieve this, we address gaps and inefficiencies in scientific research by supporting high-risk, high-reward projects while leveraging world-class business and scientific expertise. We also aim to foster innovation in funding processes, to increase philanthropic impact in health grantmaking in Canada.